Category: impact giving

Basic, discovery, validation and development research (preclinical research) are vital components of bringing new medical innovations to the people in need.  These innovations include new medicines, vaccines, diagnostics and devices. The Conversation has recently published a good lay article describing the process of bringing a new medicine to market outlining the contents included in the […]

VIEW POST

Measurements and rewards influence behaviour. They not only influence what is performed, but also what is not. Key performance indicators are often used to measure the performance of employees; they prioritise activities and drive behaviour. The measures, rewards and potential of future grant successes that funders of research and their employers put into the research […]

VIEW POST

Australia’s innovation efficiency is a wicked problem needing a solution.  The ability for Australia to capitalise on its research efforts has consistently ranked well below expectations. One of the key opportunities for philanthropy is to innovate and test solutions that can be scaled to assist in solving wicked problems such as this and contribute towards […]

VIEW POST

I started writing this post to provoke a conversation and scratch the surface on an important issue.  There are many differing points of view and most are valid, and less valid at the same time depending on the lens you are looking through. Measuring impact from research requires a more sophisticated or complex conversation than […]

VIEW POST

The Age recently published an article ‘The dodgy academic journals publishing anti-vaxxers and other ‘crappy science’.   The article describes a booming black market duping academics into submitting their research for a fee of up to $3000 a paper and notes the increasing number of reputable journals charging researchers to submit or cite their publications. We […]

VIEW POST

  In order to harness the benefits from medical research it is important to bring all key stakeholders together, including philanthropy, industry, government and academia.  NFMRI’s conference uniquely provides this opportunity, creating an interactive forum to discuss opportunities, issues and ideas. We encourage delegates to submit questions in advance and contribute to the conversation. The […]

VIEW POST

Professor Michael Good AO talks about NFMRI funding and his research into a new Strep vaccine for rheumatic heart disease and deep tissue infections   The ‘Valley of Death’ grant that we recently received from the National Foundation for Medical Research and Innovation (NFMRI) has been a Godsend to our streptococcal vaccine project. Whist there […]

VIEW POST

In the presence of industry, business and research experts and our partner representatives from the NSW Department of Primary Industries, on Wednesday 10 December we awarded our 2015 grants. This followed a recent strategy implementation that saw our Foundation change its focus towards advancing innovations and enabling collaborations, with funding available via competitive grants rounds […]

VIEW POST

Assuming both are important where do you think priority should lie?

VIEW POST

Australia excels in biomedical research but sucks at commercialisation. Professor Frank Gannon says that needs to change. This article, written by Graeme O’Neill, previously appeared in Lab + Life Scientist.  Professor Gannon is director of the QIMR Berghofer Medical Research Institute, formerly known as the Queensland Institute of Medical Research. The institute is dedicated to […]

VIEW POST

make-a-donation

partner-enquiry

thinking-out-land

Loading

Looking beyond the research and considering translational needs when funding research. How well are your expectations, application and review processes, measures of success and funding strategy aligned with the next steps for translation?

Thank you for voting
You have already voted on this poll!
Please select an option!